BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19780859)

  • 1. CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
    Micheloud D; González-Nicolás J; Berenguer J; Lorente R; Miralles P; López JC; Cosín J; Catalán P; Muñoz-Fernández M; Resino S
    HIV Med; 2010 Mar; 11(3):161-9. PubMed ID: 19780859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
    Kronenberger B; Herrmann E; Hofmann WP; Wedemeyer H; Sester M; Mihm U; Ghaliai T; Zeuzem S; Sarrazin C
    J Leukoc Biol; 2006 Aug; 80(2):298-308. PubMed ID: 16735696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
    Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
    J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.
    Massanella M; Tural C; Papagno L; Garcia E; Jou A; Bofill M; Autran B; Clotet B; Blanco J
    Antivir Ther; 2010; 15(3):333-42. PubMed ID: 20516553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients.
    Milazzo L; Meroni L; Galazzi M; Cesari M; Caramma I; Marchetti G; Galli M; Antinori S
    J Viral Hepat; 2009 Jul; 16(7):479-84. PubMed ID: 19215577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
    Soriano V; Núñez M; Sánchez-Conde M; Barreiro P; García-Samaniego J; Martín-Carbonero L; Romero M; González-Lahoz J
    Antivir Ther; 2005; 10(1):167-70. PubMed ID: 15751774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
    Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee JH; Roth WK; Zeuzem S
    Hepatology; 2001 Jun; 33(6):1518-26. PubMed ID: 11391542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment.
    Soldevila B; Alonso N; Martínez-Arconada MJ; Morillas RM; Planas R; Sanmartí AM; Martínez-Cáceres EM
    J Viral Hepat; 2011 Jun; 18(6):384-92. PubMed ID: 20487258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.
    Salmon-Céron D; Lassalle R; Pruvost A; Benech H; Bouvier-Alias M; Payan C; Goujard C; Bonnet E; Zoulim F; Morlat P; Sogni P; Pérusat S; Tréluyer JM; Chêne G;
    Clin Infect Dis; 2003 May; 36(10):1295-304. PubMed ID: 12746776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients.
    Ballesteros AL; Fuster D; Planas R; Clotet B; Tural C
    J Antimicrob Chemother; 2005 Jun; 55(6):824-7. PubMed ID: 15886264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection.
    Meroni L; Milazzo L; Menzaghi B; Mazzucchelli R; Mologni D; Morelli P; Broggini V; Adorni F; Galli M; Riva A
    Clin Exp Immunol; 2007 Jan; 147(1):53-9. PubMed ID: 17177963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.